Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ · Healthcare
Xeris Biopharma Holdings, Inc. Cash Flow 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Cash Flow | 28.6M | -37.0M | -47.0M | -102.9M | -95.5M | -80.6M |
| Depreciation & Amort. | — | — | — | — | — | — |
| Investing Activities | ||||||
| Capital Expenditure | — | — | — | — | 1.1M | 377,000 |
| Free Cash Flow | — | — | — | — | -96.6M | -80.9M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Buybacks | — | — | — | — | — | — |
Xeris Biopharma Holdings, Inc. Cash Flow — FAQ
Xeris Biopharma Holdings, Inc. (XERS) cash flow over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see XERS's cash flow history?
The chart and table above show Xeris Biopharma Holdings, Inc.'s cash flow by year and by quarter, including the growth rate.